Nissay Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Nissay Asset Management's ABMD Position: Q4 2022 in Review
Nissay Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 5,082 shares — an estimated $1.25M sold.
Nissay Asset Management first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $3.17M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Nissay Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Nissay Asset Management sold 5,082 Abiomed Inc shares in Q4 2022, an estimated $1.25M.
- Nissay Asset Management first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
- Nissay Asset Management's Abiomed Inc position peaked at $3.17M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Nissay Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.